Role of animal models in selecting antiviral combinations for clinical studies

Antiviral Research

Volumn 29, Issue 1, 1996, Pages 57-59

  Kern, Earl R ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

Animal models; Combination antiviral therapy

Indexed keywords

ACICLOVIR; ANTIBODY; ANTIVIRUS AGENT; CIDOFOVIR; CYTOKINE; FOSCARNET; GANCICLOVIR; IMMUNOSTIMULATING AGENT; INTERFERON; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL MODEL; CONFERENCE PAPER; CYTOMEGALOVIRUS INFECTION; DRUG EFFICACY; GUINEA PIG; HEPATITIS B; HEPATITIS C; HERPES SIMPLEX; HUMAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RAT; TECHNIQUE; VIRUS INFECTION;

EID: 0029928868     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/0166-3542(95)00917-5     Document Type: Conference Paper

References (11)

1. Bernstein, D.I. et al. (1993) Effects of therapy with an immunomodulator (imiquimod, R-837) alone and with acyclovir on genital HSV-2 infection in guinea-pigs when begun after lesion development. Antiviral Res. 20, 45-55.
2. Dieterich, D.T. et al. (1992) Concurrent use of ganciclovir and foscarnet to treatment cytomegalovirus infection in AIDS patients. J. Infect. Dis. 167, 1184-1188.
3. Ellis, M.N. et al. (1989) Synergistic therapy by acyclovir and A1110U for mice orofacially infected with herpes simplex virus. Antimicrob. Agents Chemother. 33, 1691-1696.
4. Freitas, V.R. et al. (1989) Increased efficacy of ganciclovir in combination with foscarnet against cytomgalovirus and herpes simplex virus type 2 in vitro and in vivo. Antiviral Res. 12, 205-212.
5. Gardner, M.B. (1991) Simian and feline immunodeficiency viruses: animal lentivirus models for evaluation of AIDS vaccines and antiviral agents. Antiviral Res. 15, 267-286.
6. Kern, E.R. (1990) Preclinical evaluation of antiviral agents. In: G.J. Galasso, T. Merigan, and R.J. Whitley (Eds), Antiviral Agents and Viral Diseases of Man, pp. 87-123, Raven Press, New York.
7. Kern, E.R. (1991) The value of animal models to evaluate agents with potential activity against human cytomegalovirus, In: J.A. Zaia (Ed), Pathogenesis of Human Cytomegalovirus Associated Diseases. Transplant. Proc. 23: (Suppl 3), 152-155.
8. Rubin, R.H. et al. (1989) Combined antibody and ganciclovir treatment of murine cytomegalovirus-infected normal and immunosuppressed BALB/c mice. Antimicrob. Agents Chemother. 33, 1975-1979.
9. Safrin, S. et al. (1993) Topical treatment of infection with acyclovir-resistant mucocutaneous herpes simplex virus with the ribonucleotide reductase inhibitor 348U87 in combination with acyclovir. Antimicrob. Agents Chemother. 37, 975-979.
10. Schinazi, R.F. (1987) Drug combinations for treatment of mice infected with acyclovir-resistant herpes simplex virus. Antimicrob. Agents Chemother. 31, 477-479.
11. Zeidner, N.S. et al. (1990) Alpha interferon (2b) in combination with zidovudine for the treatment of presymptomatic feline leukemia virus-induced immunodeficiency syndrome. Antimicrob. Agents Chemother. 34, 1749-1756.